Immunovant, Inc. vs 4D Molecular Therapeutics, Inc., risk disclosures compared

3topics both disclose

7only Immunovant, Inc.

1only 4D Molecular Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Immunovant, Inc.	4D Molecular Therapeutics, Inc.
Ransomware	18	3
Internal Control	6	6
Restatement	2	5

Only Immunovant, Inc.

Topic	Filings
Regulatory Reporting	23
Cross Border Data Transfer	18
Material Weakness	5
Vendor Risk Management	3
Business Continuity	1
Data Breach	1
Enforcement Action	1

Only 4D Molecular Therapeutics, Inc.

Topic	Filings
Third Party Risk Management	3

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Immunovant, Inc. · 4D Molecular Therapeutics, Inc. · All companies